Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

NCT06828120 is registered in ClinicalTrials.gov with Bun Yao Biotechnology Co., Ltd as lead sponsor.

NCT NCT06828120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06828120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
Lead sponsor
Bun Yao Biotechnology Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
February 20, 2025
Completion date
September 17, 2025
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease)